PTEN公司
PI3K/AKT/mTOR通路
癌症研究
生物
蛋白激酶B
小RNA
细胞生长
细胞
作者
Yong-Jie Xu,Rui-Shi Wei,Xin-Hua Li,Qiang Li,Jian-Rong Yu,Xiao-Fei Zhuang
出处
期刊:Epigenomics
[Future Medicine]
日期:2022-02-01
卷期号:14 (3): 121-138
标识
DOI:10.2217/epi-2021-0229
摘要
Aims: We aim to investigate the effects of miR-421 on lipid metabolism in non-small cell lung cancer (NSCLC). Methods: The miR-421 expression and PTEN mRNA level in tumor tissues, adjacent normal tissues, human lung epithelial cells and NSCLC cell lines were detected with reverse transcription quantitative real-time PCR. Results: MiR-421 was increased, and PTEN was reduced remarkably in tumor tissues and NSCLC cell lines. Down-regulated miR-421 suppressed lipid accumulation, cell proliferation, migration and invasion, whereas overexpression of miR-421 had the opposite effects. MiR-421 directly targeted PTEN and negatively regulated PTEN expression. MiR-421 activated PI3K/AKT/mTOR pathway through regulating PTEN. Conclusion: MiR-421 promotes lipid metabolism through targeting PTEN via PI3K/AKT/mTOR pathway activation in NSCLC, indicating that miR-421 can be a latent therapeutic target for NSCLC.
科研通智能强力驱动
Strongly Powered by AbleSci AI